Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
XY03-EA / Shijiazhuang Yiling Pharma
XY03-EA, NCT05515393: A Study of Tablets in the Treatment of Acute Ischemic Stroke	Enrolling by invitation	2	420	RoW	XY03-EA, XY03-EA Placebo	Shijiazhuang Yiling Pharmaceutical Co. Ltd, First Affiliated Hospital, Sun Yat-Sen University	Acute Ischemic Stroke	12/23	12/23